Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian.
With yet another quarter where Pfizer handily beat consensus earnings expectations, it’s even more clear that CEO Albert Bourla is already well on his way toward getting Pfizer back on track ...
In turn, this could actually bring a new wave of long-term growth for Nvidia. Palantir CEO Alex Karp recently shared some interesting thoughts on the DeepSeek development. Alex Karp is a PhD., ...
Demetrius Frazier, 52, was pronounced dead at 6:36 p.m. at a south Alabama prison for his murder conviction in the 1991 rape and killing of Pauline Brown, 41. It was the first execution in Alabama ...
The method's first use ever only dates back to a little over a year ago, when Alabama executed Kenneth Eugene Smith in January of 2024. Frazier is now the fourth inmate to die by inhalation of ...
On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...
The continued soaring success of Keytruda speaks to the triumphant legacy of Merck’s former CEO, the legendary Ken Frazier, who delivered countless blockbusters during his tenure at the top from ...
Before that, she spent the better part of two decades at EMD Serono, Merck KGaA’s U.S. pharma subsidiary ... M.D., Moderna’s president, and CEO Stephane Bancel. More recently, Moderna has ...
The newspaper reported that Kenneth Bresnahan, the Detroit investigator that Frazier reportedly admitted Brown's murder to, called Frazier the "most vicious person" he had ever come across.
As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.
Merck CEO Robert Davis said on an earnings call that Gardasil inventory in China "remains elevated at above normal levels," noting that demand for the shot has not recovered to the level the ...